                         SEQUENCE LISTING

<110>  Centro de Inmunologa Molecular
 
<120>  Antibodies of increased affinity for the epidermal growth factor receptor and its derived fragments

<130>  572017CU00

<160>  29    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  1

Gly Tyr Thr Phe Thr Asp Tyr Tyr Ile Tyr 
1               5                   10  


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  2

Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  3
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  3

Thr Arg Gln Gly Leu Trp Phe Asp Ser Asp Gly Arg Gly Phe 
1               5                   10                  


<210>  4
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  4

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser 
            20                  25  


<210>  5
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  5

Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile 
1               5                   10              


<210>  6
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  6

Arg Val Thr Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr Met Glu 
1               5                   10                  15      


Leu Ser Ser Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys 
            20                  25                  30  


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  7

Phe Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser 
1               5                   10          


<210>  8
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DNA recombinant technology

<400>  8

Gly Gly Ile Asn Pro Thr Thr Gly Gly Ser Asn Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  9

Gly Tyr Thr Phe Thr Asn Tyr Tyr Ile Tyr 
1               5                   10  


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  10

Gly Gly Ile Asn Pro Thr Thr His Ala Gln Ala Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  11

Gly Gly Ile Asn Pro Leu Arg Gly Gln Ala Val Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  12

Gly Gly Ile Asn Pro Gln Thr Ser Gln Asn His Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  13

Gly Tyr Pro Phe Ser Asn Tyr Tyr Ile Tyr 
1               5                   10  


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  14

Gly Gly Ile Asn Pro Thr Ser Gly Val Ser Asn Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  15

Gly Tyr Asn Phe Thr Asp Tyr Tyr Ile Tyr 
1               5                   10  


<210>  16
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  16

Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser His Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  17

Gly Gly Ile Asn Pro Asn Asn Gln Gln Ser His Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  18
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  18

Gly Gly Ile Asn Pro Val Thr Gln Arg Pro Val Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  19

Gly Tyr Pro Phe Thr Asn Tyr Tyr Ile Tyr 
1               5                   10  


<210>  20
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  20

Gly Gly Ile Asn Pro Asn Asn Gln Gln Ser His Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  21
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  21

Gly Gly Ile Asn Pro Val Thr Gln Arg Pro Val Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


<210>  22
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  22

Arg Ser Ser Gln Asn Ile Val His Ser Asn Gly Asn Thr Tyr Leu Asp 
1               5                   10                  15      


<210>  23
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  23

Lys Val Ser Asn Arg Phe Ser 
1               5           


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  24

Phe Gln Tyr Ser His Val Pro Trp Thr 
1               5                   


<210>  25
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  25

Gln Val Gln Leu Gln Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ser 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser 
            20                  25  


<210>  26
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  26

Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile 
1               5                   10              


<210>  27
<211>  59
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  27

Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Ile Gly Gly Ile Asn Pro 
1               5                   10                  15      


Thr Ser Gly Gly Ser Asn Phe Asn Glu Lys Phe Lys Thr Arg Val Thr 
            20                  25                  30          


Ile Thr Ala Asp Glu Ser Ser Thr Thr Ala Tyr Met Glu Leu Ser Ser 
        35                  40                  45              


Leu Arg Ser Glu Asp Thr Ala Phe Tyr Phe Cys 
    50                  55                  


<210>  28
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  28

Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys Arg 
1               5                   10      


<210>  29
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  by DNA recombinant technology

<400>  29

Gly Gly Ile Asn Pro Thr Ser Gly Gly Ser Ile Phe Asn Glu Lys Phe 
1               5                   10                  15      


Lys Thr 
        


